Clinical Trial Update: Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating allogeneic heart stem cells for myocardial regeneration in myocardial infarction; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Allogeneic heart stem cells

Snippet

Sponsor: Capricor Inc. | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-04-09